Literature DB >> 7804003

Glycosylation of glycoprotein 55 encoded by the anaemia-inducing strain of Friend spleen focus-forming virus.

J Völker1, H Geyer, R Geyer.   

Abstract

Normal rat kidney cells, non-productively infected with the anaemia-inducing variant of Friend spleen focus-forming virus (F-SFFVA), were metabolically labelled with [2-3H]mannose. The primary translation product of the viral envelope gene (env), representing a glycoprotein with an apparent molecular M(r) of 55,000 (gp55), was isolated from cell lysates by immunoaffinity chromatography and purified by preparative SDS/PAGE. Radiolabelled oligosaccharides, released from tryptic glycopeptides by treatment with endo-beta-N-acetylglucosaminidase H, were characterized chromatographically, by enzymic digestion and by acetolysis. The results revealed that F-SFFVA gp55 obtained from this source carried predominantly oligomannose type sugar chains with five to nine mannoses. As a characteristic feature, glycans with seven to nine mannoses contained, in part, an additional glucose residue. Although the amount of glucosylated species found was higher in F-SFFVA gp55 (about 25% of total endo-H-sensitive oligosaccharides) than in gp55 of the corresponding polycythaemia-inducing variant (F-SFFVP, 16.3%), the overall glycosylation pattern of the F-SFFVA env product closely resembled that of F-SFFVP gp55 [Strube et al. (1988) J Biol Chem 263:3762-71]. Hence, our results demonstrate that the different intracellular processing and transport of the primary F-SFFVA env product cannot be attributed to aberrant trimming of its oligomannose type glycans.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7804003     DOI: 10.1007/bf00731153

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  41 in total

Review 1.  Transforming genes and target cells of murine spleen focus-forming viruses.

Authors:  W Ostertag; C Stocking; G R Johnson; N Kluge; R Kollek; T Franz; N Hess
Journal:  Adv Cancer Res       Date:  1987       Impact factor: 6.242

2.  BioGel P-4 column chromatography of oligosaccharides: effective size of oligosaccharides expressed in glucose units.

Authors:  A Kobata; K Yamashita; S Takasaki
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  Isolation and fractionation of glycoprotein glycans in small amounts.

Authors:  R Geyer; H Geyer
Journal:  Methods Mol Biol       Date:  1993

5.  Envelope gene of the Friend spleen focus-forming virus: deletion and insertions in 3' gp70/p15E-encoding region have resulted in unique features in the primary structure of its protein product.

Authors:  L Wolff; E Scolnick; S Ruscetti
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

6.  Activation of erythropoietin receptors by Friend viral gp55 and by erythropoietin and down-modulation by the murine Fv-2r resistance gene.

Authors:  M E Hoatlin; S L Kozak; F Lilly; A Chakraborti; C A Kozak; D Kabat
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

7.  Friend spleen focus-forming virus induces factor independence in an erythropoietin-dependent erythroleukemia cell line.

Authors:  S K Ruscetti; N J Janesch; A Chakraborti; S T Sawyer; W D Hankins
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

8.  Biochemical characterization of cell-associated and extracellular products of the Friend spleen focus-forming virus env gene.

Authors:  A Pinter; W J Honnen
Journal:  Virology       Date:  1989-11       Impact factor: 3.616

9.  Glycosylation pattern and processing of envelope gene products encoded by glycosylation mutants of Friend spleen focus-forming virus.

Authors:  A Freis; S Rau; R W Friedrich; R Geyer
Journal:  Glycobiology       Date:  1993-10       Impact factor: 4.313

Review 10.  Molecular biology of Friend viral erythroleukemia.

Authors:  D Kabat
Journal:  Curr Top Microbiol Immunol       Date:  1989       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.